Published in Clin Exp Immunol on October 01, 1995
Small vessel vasculitis of the lung. Thorax (2000) 1.25
Anti-PR3 immune responses induce segmental and necrotizing glomerulonephritis. Clin Exp Immunol (2009) 1.04
Lupus-specific kidney deposits of HSP90 are associated with altered IgG idiotypic interactions of anti-HSP90 autoantibodies. Clin Exp Immunol (2002) 0.92
The clinical utility of ANCA positivity. Ann Rheum Dis (1996) 0.89
Anti-DNA and antiphospholipid antibodies in IVIG preparations: in vivo study in naive mice. J Clin Immunol (1998) 0.81
C-ANCA-positive IgG fraction from patients with Wegener's granulomatosis induces lung vasculitis in rats. Clin Exp Immunol (2002) 0.80
New methods of treatment in an experimental murine model of systemic lupus erythematosus induced by idiotypic manipulation. Ann Rheum Dis (1997) 0.75
Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med (1992) 13.29
Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet (1985) 10.67
The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum (1990) 8.67
Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med (1983) 8.26
Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A (1990) 7.19
Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation. J Cell Biol (1983) 5.73
Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood (1989) 5.08
Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. N Engl J Med (1983) 4.43
Limited forms of angiitis and granulomatosis of Wegener's type. Am J Med (1966) 4.37
Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS Suppl (1989) 3.81
Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med (1990) 3.37
Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest (1989) 3.34
Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis. Ann Intern Med (1989) 3.33
Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med (1989) 2.94
Antibiotic proteins of human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1989) 2.59
Antineutrophil cytoplasmic antibodies, cystic fibrosis, and infection. Lancet (1991) 2.41
Relapses in Wegener's granulomatosis: the role of infection. Br Med J (1980) 2.29
Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet (1990) 2.12
Infection, thyroid disease, and autoimmunity. Endocr Rev (1993) 2.08
Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc Natl Acad Sci U S A (1988) 1.91
Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol (1988) 1.83
Identification of an autoantibody to vascular endothelial cell-specific antigens in patients with systemic vasculitis. Am J Med (1989) 1.78
Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A (1991) 1.77
Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. J Clin Invest (1984) 1.72
Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model. J Exp Med (1993) 1.63
Immunochemical similarities between monoclonal antibacterial Waldenstrom's macroglobulins and monoclonal anti-DNA lupus autoantibodies. J Exp Med (1985) 1.49
Plasmalemmal proteins of cultured vascular endothelial cells exhibit apical-basal polarity: analysis by surface-selective iodination. J Cell Biol (1986) 1.44
Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies. Clin Exp Immunol (1991) 1.42
Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest (1992) 1.39
Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis. Clin Exp Immunol (1984) 1.37
Detection and quantitation of anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis by ELISA using affinity-purified antigen. J Immunol Methods (1988) 1.33
Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides. Clin Exp Immunol (1990) 1.26
Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis. Clin Exp Immunol (1991) 1.21
Autoantibodies to endothelial cells and neutrophil cytoplasmic antigens in systemic vasculitis. Clin Exp Immunol (1990) 1.18
Human endothelial cells express integrin receptors on the luminal aspect of their membrane. Blood (1992) 1.17
Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol (1988) 1.15
Resistance of MHC class I-deficient mice to experimental systemic lupus erythematosus. Science (1993) 1.13
The sera of patients with Klebsiella infections contain a common anti-DNA idiotype (16/6) Id and anti-polynucleotide activity. Clin Exp Immunol (1987) 1.12
Autoimmunity to lysosomal enzymes: new clues to vasculitis and glomerulonephritis? Immunol Today (1991) 1.12
Wegener's granulomatosis occurring in siblings. Br J Rheumatol (1991) 1.10
Pathogenic idiotypes of autoantibodies in autoimmunity: lessons from new experimental models of SLE. FASEB J (1990) 1.06
The treatment of Wegener's granulomatosis with trimethoprim/sulfamethoxazole: illusion or vision? Arthritis Rheum (1988) 1.05
Idiotypic induction of autoimmunity: a new aspect of the idiotypic network. FASEB J (1994) 1.03
A common anti-DNA idiotype in sera of patients with active pulmonary tuberculosis. Arthritis Rheum (1987) 1.01
The genetic regulation of the induction of experimental SLE. Immunology (1990) 1.00
The role of the endothelium in systemic vasculitis. J Autoimmun (1993) 0.98
ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin. J Autoimmun (1993) 0.98
Indirect immunofluorescence examination for IgG-ANCA in sera submitted for the 1st international workshop on ANCA, 1988. APMIS Suppl (1989) 0.98
The importance of the pathogenic 16/6 idiotype in the induction of SLE in naive mice. Scand J Immunol (1990) 0.95
The new ACPA/ANCA nomenclature. Neth J Med (1990) 0.95
The putative role of cytokines in the induction of primary anti-phospholipid syndrome in mice. Clin Exp Immunol (1992) 0.91
Relationship between anti-phospholipid and anti-endothelial cell antibodies: further characterization of the reactivity on resting and cytokine-activated endothelial cells. Clin Exp Rheumatol (1992) 0.90
ANCA and infection. Lancet (1991) 0.89
Transfer of multiple sclerosis into severe combined immunodeficiency mice by mononuclear cells from cerebrospinal fluid of the patients. Proc Natl Acad Sci U S A (1992) 0.88
Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells. Clin Immunol Immunopathol (1992) 0.85
The effect of cyclosporin A on early and late stages of experimental lupus. Arthritis Rheum (1992) 0.84
HLA antigen frequencies and Wegener's granulomatosis. Clin Otolaryngol Allied Sci (1991) 0.82
The effect of intravenous gamma-globulin on the induction of experimental antiphospholipid syndrome. Clin Immunol Immunopathol (1993) 0.82
Effects of aging on the induction of experimental systemic lupus erythematosus (SLE) in mice. Mech Ageing Dev (1991) 0.78
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet (1985) 10.67
Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell (1997) 9.60
Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group. N Engl J Med (1995) 6.23
The product of the mei3+ gene, expressed under control of the mating-type locus, induces meiosis and sporulation in fission yeast. EMBO J (1987) 4.45
Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. N Engl J Med (1983) 4.43
Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int (1998) 4.31
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum (2001) 4.06
Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med (2000) 3.96
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis (1996) 3.68
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus (2003) 3.61
International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA) Am J Clin Pathol (1999) 3.31
Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum (1997) 3.29
A pathogenic bacterium triggers epithelial signals to form a functional bacterial receptor that mediates actin pseudopod formation. EMBO J (1996) 3.11
Idiotypic cross-reactions of monoclonal human lupus autoantibodies. J Exp Med (1983) 2.96
The neuropathic postural tachycardia syndrome. N Engl J Med (2000) 2.86
Fluvastatin inhibits up-regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells. J Thromb Haemost (2004) 2.79
Violence victimization after HIV infection in a US probability sample of adult patients in primary care. Am J Public Health (2000) 2.75
Infection with the human immunodeficiency virus in prisoners: meeting the health care challenge. Am J Med (1993) 2.68
Rheumatology in Israel. Br J Rheumatol (1996) 2.66
Fibronectin and vitronectin regulate the organization of their respective Arg-Gly-Asp adhesion receptors in cultured human endothelial cells. J Cell Biol (1988) 2.64
Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis (1994) 2.58
Serum antibodies in epilepsy and seizure-associated disorders. Neurology (2005) 2.53
Attitudes of women and men physicians. Am J Public Health (1979) 2.47
Delayed medical care after diagnosis in a US national probability sample of persons infected with human immunodeficiency virus. Arch Intern Med (2000) 2.41
Quality of life in persons with human immunodeficiency virus infection: measurement by the Medical Outcomes Study instrument. Ann Intern Med (1992) 2.40
DAP kinase links the control of apoptosis to metastasis. Nature (1997) 2.39
Suppression of lymphocyte stimulation following bereavement. JAMA (1983) 2.37
Abdominal injuries without hemoperitoneum: a potential limitation of focused abdominal sonography for trauma (FAST) J Trauma (1997) 2.36
Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet (1998) 2.31
Enteropathogenic Escherichia coli protein secretion is induced in response to conditions similar to those in the gastrointestinal tract. Infect Immun (1997) 2.23
Production of autoantibodies by human-human hybridomas. J Clin Invest (1982) 2.22
Sucl+ encodes a predicted 13-kilodalton protein that is essential for cell viability and is directly involved in the division cycle of Schizosaccharomyces pombe. Mol Cell Biol (1987) 2.13
Hierarchical pattern of mucosal candida infections in HIV-seropositive women. Am J Med (1990) 2.11
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis (2010) 2.09
Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitis. Arthritis Rheum (1995) 2.09
Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet (1984) 2.08
Enterohemorrhagic Escherichia coli O157:H7 produces Tir, which is translocated to the host cell membrane but is not tyrosine phosphorylated. Infect Immun (1999) 2.04
Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) (2001) 2.02
Use of mental health and substance abuse treatment services among adults with HIV in the United States. Arch Gen Psychiatry (2001) 1.98
Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy. J Clin Invest (2000) 1.98
Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation (1996) 1.92
Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc Natl Acad Sci U S A (1988) 1.91
Colchicine treatment for recurrent pericarditis. A decade of experience. Circulation (1998) 1.87
A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity. Arthritis Rheum (1999) 1.85
High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-kappaB activation. Nat Med (2000) 1.82
Stress fractures in military recruits. A prospective study showing an unusually high incidence. J Bone Joint Surg Br (1985) 1.79
Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome. Clin Exp Immunol (2014) 1.78
Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A (1991) 1.77
Binding of cytoskeletal proteins by monoclonal anti-DNA lupus autoantibodies. Clin Immunol Immunopathol (1984) 1.76
Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma. Clin Cancer Res (2001) 1.75
Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut (2005) 1.73
[Chronic fatigue syndrome--a defined unity?]. Ugeskr Laeger (1994) 1.71
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis (2009) 1.69
Blast injuries: bus versus open-air bombings--a comparative study of injuries in survivors of open-air versus confined-space explosions. J Trauma (1996) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression. Genes Immun (2007) 1.66
QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block. Arthritis Rheum (2000) 1.65
Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int (2000) 1.64
Patients with anticentromere antibodies, clinical features, diagnoses and evolution. Br J Rheumatol (1993) 1.64
Human anticardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in BALB/c mice. Arthritis Rheum (1998) 1.63
Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS). J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.61
Granulocyte-specific antinuclear antibodies. Possible significance for the pathogenesis, clinical features and diagnosis of rheumatoid arthritis. Allergy (1980) 1.59
No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. J Rheumatol (1996) 1.58
Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. Eur J Endocrinol (1995) 1.58
Pharmacotherapy of panic disorder: proposed guidelines for the family physician. J Am Board Fam Pract (1998) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Ann Rheum Dis (2001) 1.55
Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus. Arthritis Rheum (1984) 1.53
Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis (2004) 1.53
Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis (2010) 1.52
Tumor necrosis factor mRNA localized to Paneth cells of normal murine intestinal epithelium by in situ hybridization. J Exp Med (1990) 1.52
Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease. Genes Immun (2004) 1.52
Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors. Ann Rheum Dis (2007) 1.51
Lifetime co-morbidities between social phobia and mood disorders in the US National Comorbidity Survey. Psychol Med (1999) 1.50
Immunologic and genetic factors in autoimmune diseases. N Engl J Med (1984) 1.50
Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care (1992) 1.49
Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection. Clin Exp Immunol (1998) 1.49
Elevated homocysteine levels in patients with Raynaud's syndrome. J Rheumatol (1999) 1.49
The prevalence of coeliac disease antibodies in patients with the antiphospholipid syndrome. Lupus (2003) 1.48
Detection of cross-reactive anti-DNA antibody idiotypes in the serum of systemic lupus erythematosus patients and of their relatives. Arthritis Rheum (1985) 1.48
Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis (2003) 1.48
Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity. Ann Rheum Dis (2005) 1.48
Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant (1998) 1.47
Characterization of a calcium-activated chloride channel as a shared target of Th2 cytokine pathways and its potential involvement in asthma. Am J Respir Cell Mol Biol (2001) 1.47
Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS. Clin Infect Dis (1994) 1.46
Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation. Arthritis Rheum (1997) 1.45
Neonatal lupus: fetal myocarditis progressing to atrioventricular block in triplets. Lupus (2003) 1.45
Intravenous line diameter: is bigger really better? Mil Med (1997) 1.45
Autoantibodies in neoplasia. An unresolved enigma. Cancer (1990) 1.45
Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role. Scand J Gastroenterol (1995) 1.45
Influence of brain and behavior on the immune system. Science (1976) 1.44
Role of beta 2-glycoprotein I in the antiphospholipid antibody binding to endothelial cells. Lupus (1995) 1.44
Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study. Rheumatology (Oxford) (2007) 1.44
The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome--molecular mimicry? J Rheumatol (2000) 1.44